-
1.发明申请公开(公告)号：US20050181075A1
公开(公告)日：2005-08-18
申请号：US10718350
申请日：2003-11-21
CPC分类号： A61K36/00
摘要： “Pharmacological enhancement and manufacturing method of the antiviral compound” can be categorized into the combined patent of the pharmacological activity as well as method of isolating and purifying the naturing material. Our product adopts 9 medicinal material which are processed strictly. The stable and high quality is ensured by the WLD resin adsorption and gas chromatography. The antiviral prevention and treatment is the most urgent but unsolved problem before the American doctors. The antiviral compound has an unexpected effect on a broad spectrum of viruses including RSV, Adenovirus type 3, Influenza A1 and A3. The antiviral effect on mouse Influenza A1 is very obvious. The definite efficacy in the treatment of acute pharyngitis and tonsillitis have been proved by the clinical trial which showed the total effective rate in the above two disease were 92.3% and 87.5% respectively.
摘要翻译： “抗病毒化合物的药理学增强和制造方法”可以分为药理活性的组合专利以及分离和纯化变性材料的方法。 我们的产品采用严格加工的9种药材。 通过WLD树脂吸附和气相色谱法确保稳定和高质量。 抗病毒预防和治疗是美国医生面临的最迫切但尚未解决的问题。 抗病毒化合物对广泛的病毒包括RSV，3型腺病毒，甲型和甲型流感病毒具有意想不到的效果。 对小鼠流感A1的抗病毒作用非常明显。 治疗急性咽炎和扁桃体炎的疗效已经通过临床试验证明，上述两种疾病的总有效率分别为92.3％和87.5％。
-
2.发明申请Digital indicator that can record human's wrist radial artery blood vessel pulsing information 审中-公开数字指示器可记录人体腕桡动脉血管脉搏信息公开(公告)号：US20050148886A1
公开(公告)日：2005-07-07
申请号：US10746365
申请日：2003-12-29
IPC分类号： A61B5/02
CPC分类号： A61B5/02 , A61B5/6824 , A61B2560/0406
摘要： A digital indicator that can record human's wrist radial artery blood vessel pulsing information, consists of tentacle, pressure-adding device, pressure meter, controlling device, change alter, storing device, digital transition storing device, input connection device, battery and circuit board device. The invention uses wrist radial artery digital indicator, after collecting 18 kinds of artery blood vessel pulse standard value, graphs on radial artery, edits them into standard pattern data base software, provides the user that after the user input the information from the digital indicator, the determined input information for consulting results will be the output, decide the diagnostic of re-segmenting type of specific disease and disease group of 18 kinds of radial artery blood vessel pulse standard value, the difference between the determined value and the standard value could reason out the specific diagnosing result. It is a kind of innovation invention for American clinical medicine science.
摘要翻译： 一种可记录人体腕桡动脉血管脉搏信息的数字指示器，包括触手，加压装置，压力表，控制装置，变更存储装置，数字转换存储装置，输入连接装置，电池和电路板装置 。 本发明采用腕桡动脉数字指示器，收集18种动脉血管脉搏标准值，桡动脉曲线，编入标准模式数据库软件，为用户提供了从数字指示器输入信息后， 确定的咨询结果输入信息将作为输出，确定18种桡动脉血管脉搏标准值的特定疾病和疾病组重新分类类型的诊断，确定值与标准值之间的差异可能导致 具体诊断结果。 它是美国临床医学科学的一种创新发明。
-
3.发明申请Pharmacological activity and manufacturing method of the production produced by 16 kinds of plant compound to improve memory 审中-公开药理活性及生产方法由16种植物化合物生产提高记忆力公开(公告)号：US20050142223A1
公开(公告)日：2005-06-30
申请号：US10745794
申请日：2003-12-29
IPC分类号： A61K36/076 , A61K36/14 , A61K36/238 , A61K36/254 , A61K36/258 , A61K36/40 , A61K36/46 , A61K36/484 , A61K36/537 , A61K36/69 , A61K36/704 , A61K36/79 , A61K36/882 , A61K36/8966 , A61K36/8968 , A61K35/78
CPC分类号： A61K36/254 , A61K36/076 , A61K36/14 , A61K36/238 , A61K36/258 , A61K36/40 , A61K36/46 , A61K36/484 , A61K36/537 , A61K36/69 , A61K36/704 , A61K36/79 , A61K36/882 , A61K36/8966 , A61K36/8968 , A61K2300/00
摘要： The medicine for delaying senescence and improving intellect are classified into eight kinds and five kinds respectively, which have brought inconvenience of taking to the patients who are eager to improve memory and delay senescence. The production produced by sixteen kinds of plant compound to improve memory applies itself to synthesize the eight kinds of medicine for delaying senescence and five kinds of medicine for improving intellect, selects sixteen kinds of plants into a compound, separate and purify natural production with WLD resin absorbing and dewatering technic under careful and strict condition. The production produced by sixteen kinds of plant compound to improve memory could improve memory hurt impediment by scopolamine distinctly It could decrease LPO in brain and liver, improve the activity of SOD in sedation, hypnosis and memory. The curative results to patiets with forgettery and insomnia in clinic validate the veracity of of pharmic activity. The pharmic activity of the compound production has presented a wide application future for its' medical use
摘要翻译： 延缓衰老和提高智力的药物分为8种和5种，对于渴望改善记忆力和延缓衰老的患者带来不便。 十六种植物化合物生产提高记忆力的生产适用于合成延迟衰老的八种药物和五种提高智力的药物，将十六种植物选择化合物，用WLD树脂分离和纯化天然产物 吸收和脱水技术在仔细和严格的条件下。 十六种植物化合物生产改善记忆能力可以明显改善东莨菪碱的记忆障碍，可以降低脑，肝中的LPO，提高SOD在镇静，催眠和记忆中的活性。 临床上遗忘和失眠的疗效证实了药学活动的真实性。 复合生产的药学活动为其医疗用途提供了广泛的应用前景
-
4.发明申请公开(公告)号：US20050106258A1
公开(公告)日：2005-05-19
申请号：US10713700
申请日：2003-11-17
IPC分类号： A61K35/64 , A61K36/00 , A61K36/21 , A61K36/234 , A61K36/258 , A61K36/43 , A61K36/505 , A61K36/54 , A61K36/79 , A61K36/8962 , A61K35/78
CPC分类号： A61K36/258 , A61K36/21 , A61K36/234 , A61K36/43 , A61K36/505 , A61K36/54 , A61K36/79 , A61K36/8962 , A61K2300/00
摘要： The reach of R. E. Furchgotte and L. J. Ignarro which leads to the “NO theory” has shock the whole world. My invention is a combined patent including pharmacology as well as isolation and purification of Bombyx moriL. In my product, Bombyx moriL accounts for 56%, others 44%. We also adopt WLD resin absorption, other purification technology, and gas chromatography The biological activity is ensured because all the process is at 85° C. My product has selective effect on cavernous body, increasing cGMP and NO by the inhibition in of PED5 enzymes. The Doppler test for the maximum and average blood flow in cavernous body also further proved the conclusion of the pharmacological activity.
摘要翻译： 导致“无理论”的R.E.Furchgotte和L.J.Ignarro的触角震惊了整个世界。 我的发明是包括药理学以及家蚕分离和纯化的组合专利。 在我的产品中，Bombyx moriL占56％，其他44％。 我们还采用WLD树脂吸收，其他净化技术和气相色谱法确保生物活性，因为所有过程都在85°C。我的产品对海绵体有选择性的作用，通过抑制PED
5个酶。 海绵体最大和平均血流量的多普勒检验进一步证实了药理活性的结论。 -
5.发明申请Pharmaceutical activity and manufaturing method of the four-plant compound immunoenhanceers 审中-公开四株植物复合免疫增强剂的药物活性和制备方法公开(公告)号：US20050142234A1
公开(公告)日：2005-06-30
申请号：US10745816
申请日：2003-12-29
CPC分类号： A61K36/40 , A61K36/232 , A61K36/804 , A61K36/815 , A61K2300/00
摘要： The injection or oral administration of exogenous IL-2 can damage the original functional equilibrium in the immune system of the body itself while modulating and enhancing immune function. The four-plant compound immunoenhancers differ from the exogenous input of IL-2 preparation. The compound products can promote the formation of endogenous IL-2 in the body, regulate and enhance the immune system. It is of greater clinical significance than the supplementation of exogenous IL-2 preparation. The four-plant ingredients are absorbed, eluted, isolated and purified with WLD resin in the rigid and delicate conditions. The quantitative analysis by finger atlas with a high performance liquid chromatograph ensures the steady and uniform quality of products. The experiment on pharmacological activity shows the compound products can facilitate the formation of spleen lymphocyte IL-2 remarkably.
摘要翻译： 外源IL-2的注射或口服给药可以损害身体免疫系统的原始功能平衡，同时调节和增强免疫功能。 四种植物化合物免疫增强剂与IL-2制剂的外源性输入不同。 复方产品可促进体内内源性IL-2的形成，调节和增强免疫系统。 比外源性IL-2制剂的补充具有更大的临床意义。 四种植物成分在刚性和微妙的条件下被WLD树脂吸收，洗脱，分离和纯化。 用高效液相色谱仪进行手指图谱的定量分析，确保产品质量稳定均匀。 药理活性实验表明，化合物可以促进脾淋巴细胞IL-2的形成。
-
6.发明申请Pharmaceutical activity and manufacturing method of the four-plant-derived coronary blood flow enhancing agent 审中-公开四植物来源的冠状动脉血流增强剂的药物活性和制备方法公开(公告)号：US20050142229A1
公开(公告)日：2005-06-30
申请号：US10745811
申请日：2003-12-29
IPC分类号： A61K36/537 , A61K35/78
CPC分类号： A61K36/286 , A61K36/236 , A61K36/505 , A61K36/537 , A61K2300/00
摘要： Nitroglycerine, the classic drug for myocardial ischemia, has been used over a century. By providing exogenous No., it alleviates the myocardial ischemia and is mainly used in the first aid of myocardial ischemia. The 4-Medicinal-Plant-Derived Coronary Blood Flow enhancing Agent is the result of strictly controlled processing procedures including the followings: extracting with Carbon Dioxide Supercritical Fluid; WLD resin adsorbing, eluting, separating and purifying; high performance liquid chromatography and fingerprint analysis to ensure the balanced and stable quality. Pharmacological experiments indicated that it increased coronary blood flow, lowered peripheral vascular resistance, regulated myocardial oxygen supply-demand balance and decreased the oxygen consumption index as well as myocardial oxygen consumption. It takes effect in a way different from Nitroglycerine. This agent can be used for the prevention and treatment of myocardial ischemia, coronary heart disease and angina pectoris.
摘要翻译： 硝酸甘油，经典药物心肌缺血，已经使用了一个多世纪。 通过提供外源性编号，可缓解心肌缺血，主要用于急性心肌缺血。 四药植物衍生的冠状动脉血流增强剂是严格控制加工程序的结果，包括：用二氧化碳超临界流体萃取; WLD树脂吸附，洗脱，分离纯化; 高效液相色谱和指纹分析，保证质量的平衡和稳定。 药理实验表明，增加冠状动脉血流量，降低外周血管阻力，调节心肌供氧需求平衡，降低氧消耗指数以及心肌耗氧量。 它以不同于硝酸甘油的方式生效。 该药物可用于预防和治疗心肌缺血，冠心病和心绞痛。
-
7.发明申请Network hospital is made as per all individuality diseases, on which one can choose corresponding commercial way for combined diet invigorating substances 审中-公开网络医院是根据个体疾病制定的，可以选择相应的商业方式联合饮食活化物质公开(公告)号：US20050114172A1
公开(公告)日：2005-05-26
申请号：US10714425
申请日：2003-11-17
CPC分类号： G06Q10/10 , G06F19/3418 , G06Q50/22
摘要： My invention is an innovation of commercial method. Characterized by the excellent combination of the intelligent specialty technology of American medicine with the intelligent commercial transaction, it realizes the integration and innovation of indirect e-commerce with direct e-commerce. It creates the integration of virtual doctor, virtual hospital, virtual enterprise and virtual shop. It meets the requirements of personal health in the course of one to one diagnosis (network doctor to consumer). The patent includes the configuration of e-business Website, page layout of browser, joining the membership, downloading the health consult software of network doctor to the terminal computer free of charge, upgrading the software free of charge, remote registration of website, usage of health diagnosis database software of network hospital, confirmation of diseases, confirmation of type of individual cases and principle of cure, glancing over commodities, confirmation of commodities and putting them into shopping vehicle, issuing order of goods, settlement and payment, transport, usage of commodities and feedback of information.
摘要翻译： 我的发明是商业方法的创新。 以美药智能专业技术与智能商业交易的优异结合为特征，实现了直接电子商务间接电子商务的整合与创新。 创建虚拟医生，虚拟医院，虚拟企业和虚拟商店的整合。 在一对一诊断过程中，它符合个人健康的要求（网络医生对消费者）。 该专利包括电子商务网站的配置，浏览器的页面布局，加入会员资格，免费下载网络医生的健康咨询软件到终端电脑，免费升级软件，网站远程注册，使用 网络医院健康诊断数据库软件，疾病确认，个案病例确认，治疗原则，商品清查，商品确认，放入购物车，发货单，结算付款，运输，使用 商品和信息反馈。
-
8.发明申请公开(公告)号：US20050144146A1
公开(公告)日：2005-06-30
申请号：US10745817
申请日：2003-12-29
CPC分类号： H04B1/7113 , H04B1/70755 , H04B1/7095 , H04B2201/70707
摘要： A decision processor for 802.11b codewords for 1 Mb and 2 Mb data rates includes a sliding correlator for the acquisition of correlation peaks. During a training interval, these correlation peaks are summed into a channel profile memory. The correlation peaks corresponding to a codeword are added into the channel profile memory, and correlation peaks corresponding to the inverse of this codeword are inverted and added into the channel profile memory during the training interval. After the training interval, a decision interval follows whereby correlation peaks are multiplied by the complex conjugate of the contents of the channel profile memory. The multiplication results are accumulated over a codeword window interval to produce a decision output.
摘要翻译： 用于1Mb和2Mb数据速率的用于802.11b码字的决策处理器包括用于获取相关峰值的滑动相关器。 在训练间隔期间，将这些相关峰值相加到通道轮廓存储器中。 对应于码字的相关峰值被加入到信道简档存储器中，并且与该码字的逆相对应的相关峰值在训练间隔期间被反转并添加到信道简档存储器中。 在训练间隔之后，确定间隔，由此将相关峰乘以信道简档存储器的内容的复共轭。 乘法结果在码字窗口间隔上累加以产生决策输出。
-
9.发明申请Pharmaceutical activity and manufacturing method of the five-plant compound hypolipemic products 审中-公开五植药复方降脂产品的药物活性和制备方法公开(公告)号：US20050142231A1
公开(公告)日：2005-06-30
申请号：US10745798
申请日：2003-12-29
CPC分类号： A61K36/424 , A61K36/296 , A61K36/638 , A61K2300/00
摘要： World Health Organization thinks that the rise in triglyceride is a major cause for occurrence of atherosclerosis. The U.S. classical anti-arteriosclerosis drug—atromid-s can reduce TG and VLDL remarkably and inhibit the synthesis and release of TG the effects of the five-plant compound hypolipemic products are better than that of atromid-s. They are made under delicate and strictly controlled conditions by absorbing, eluting, isolating and purifying the five-plant components with supercritical CO2 extraction and WLD resin absorption techniques and quantitative analysis by fingerprinting through high performance liquid chromatography to ensure the uniformity and stability of product quality. The results of experiments on pharmacological activity show the compound products have the pharmacological action to inhibit the rise in serum cholesterol in rabbit, enhance LCAT activity and reduce the content of serum cholesterol and triglyceride, clinically They can be used in the treatment of atherosclerosis and obesity.
摘要翻译： 世界卫生组织认为，甘油三酯的升高是动脉粥样硬化发生的主要原因。 美国古典抗动脉硬化药物 - atromid-s可以显着降低TG和VLDL，抑制TG的合成和释放，五植物化合物降血脂产品的效果优于atromid-s。 它们通过吸收，洗脱，分离和纯化超临界CO 2萃取和WLD树脂吸收技术的五种植物成分，并通过高效液相色谱法进行指纹图谱定量分析，在精细且严格控制的条件下制备 确保产品质量的一致性和稳定性。 药理活性实验结果表明，化合物具有抑制兔血清胆固醇升高的药理作用，提高LCAT活性，降低血清胆固醇和甘油三酯含量，临床可用于治疗动脉粥样硬化和肥胖 。
-
10.发明申请公开(公告)号：US20050108045A1
公开(公告)日：2005-05-19
申请号：US10714312
申请日：2003-11-17
CPC分类号： G06Q50/22
摘要： This invention relates to a kind of innovative technology, i.e. adopt computer FD, keyboard operating system to express the health information in the software dictionary via screen and make health result obtained. Input the disease, symptom, subtype, treatment principle, knocking code of formula, keyboard and key position for selecting and enquiring personal health condition and finding the treatment scheme which belongs to word coding technology. Through code and enquiry on the screen, medical scientific innovative system is formed to carry out the re-classified treatment to the same disease, different symptom by intelligentization. The word coding character and keyboard character by using coding method is realized to be corresponding with information shown on the screen in the structure.
摘要翻译： 本发明涉及一种创新技术，即采用计算机FD，键盘操作系统，通过屏幕来表达软件字典中的健康信息，并获得健康结果。 输入疾病，症状，亚型，治疗原则，公式敲键码，键盘和关键位置，选择和查询个人健康状况，找出属于字编码技术的治疗方案。 通过屏幕上的代码查询，形成医学科学创新体系，通过智能化对同一疾病，不同症状进行重新分类治疗。 通过使用编码方式对字编码字符和键盘字符实现与结构中屏幕上显示的信息相对应。
-
-
-
-
-
-
-
-
-
搜索结果
15 条记录 (耗时 0.016 秒)
